[1-(2-methoxy-2-oxoethyl)triazol-4-yl]methyl-trimethylazanium;2,2,2-trifluoroacetate
C11H17F3N4O4 — CID 156693135
Data last refreshed: (MolForge compound catalog, from PubChem)
About [1-(2-methoxy-2-oxoethyl)triazol-4-yl]methyl-trimethylazanium;2,2,2-trifluoroacetate
[1-(2-methoxy-2-oxoethyl)triazol-4-yl]methyl-trimethylazanium;2,2,2-trifluoroacetate (PubChem CID 156693135) has the molecular formula C11H17F3N4O4 and a molecular weight of 326.28 g/mol. Its IUPAC name is [1-(2-methoxy-2-oxoethyl)triazol-4-yl]methyl-trimethylazanium;2,2,2-trifluoroacetate.
Molecular Properties
| Compound Name | [1-(2-methoxy-2-oxoethyl)triazol-4-yl]methyl-trimethylazanium;2,2,2-trifluoroacetate |
|---|---|
| PubChem CID | 156693135 |
| Molecular Formula | C11H17F3N4O4 |
| Molecular Weight | 326.28 g/mol |
| Exact Mass | 326.12 |
| IUPAC Name | [1-(2-methoxy-2-oxoethyl)triazol-4-yl]methyl-trimethylazanium;2,2,2-trifluoroacetate |
| SMILES | COC(=O)Cn1cc(C[N+](C)(C)C)nn1.O=C([O-])C(F)(F)F |
| InChI | InChI=1S/C9H17N4O2.C2HF3O2/c1-13(2,3)7-8-5-12(11-10-8)6-9(14)15-4;3-2(4,5)1(6)7/h5H,6-7H2,1-4H3;(H,6,7)/q+1;/p-1 |
| InChIKey | BSXDJVYUXUVRQJ-UHFFFAOYSA-M |
| XLogP | -1.04 |
| TPSA | 97.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 326.28 |
| LogP ≤ 5 | -1.04 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156693135 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.